Skip to main content
. Author manuscript; available in PMC: 2016 Apr 8.
Published in final edited form as: JAMA Ophthalmol. 2016 Feb 1;134(2):137–145. doi: 10.1001/jamaophthalmol.2015.4606

Table 1.

Clinical Characteristics of the 1184 Participants with Visual QOL Evaluation during EDIC Years 17-20

DCCT Baseline (1983-1989) EDIC Years 17-20 (2011-2014)
INT(n=605) CONV(n=579) INT(n=605) CONV(n=579) P value
Age (yr) 27.5 (7.1) 26.7 (7.0) 52.8 (6.9) 51.8 (6.9) 0.0236
Female (%) 49.8 46.1 49.8 46.1 0.2104
Primary Prevention Cohort (%) 47.4 50.6 47.4 50.6 0.2759
Duration of Diabetes (yr) 6.1 (4.3) 5.7 (4.1) 30.5 (5.0) 29.9 (5.0) 0.0725
Unemployed/Retired (%) 1.3 0.5 14.4 11.6 0.1510
Married (%) 49.3 51.1 72.7 73.1 0.8985
College or Above Education (%) 73.6 73.1 90.1 90.2 0.9665
Smoking (%) 19.2 18.7 10.9 11.2 0.8619
Mean Arterial Pressure (mm Hg) * 86.0 (8.8) 86.8 (8.7) 87.6 (9.9) 87.1 (9.3) 0.3567
Hypertension (%) 3.3 3.1 65.0 69.1 0.1313
Diabetes QOL 1.9 (0.3) 1.9 (0.3) 75.1 (10.8) 74.5 (10.4) 0.2333
Depression or Psychiatric Event (%) § - - 28.2 27.6 0.8444
Eye Complications:
Retinopathy (%) <0.0001
        No Retinopathy (10/10) 47.5 50.6 10.7 5.2
        MA Only (20/(<)20) 35.8 29.5 38.7 26.1
        Mild NPDR (35/(<)35) 12.3 14.9 22.0 24.2
        Moderate or Severe NPDR (43/<44 +) 4.5 5.0 17.9 19.7
        PDR or Worse (61/<61 +) 0 0 10.7 24.9
CSME (%) 0 0 16.4 25.2 0.0002
Visual Acuity in the Worse Eye (%) 0.0483
        ≤20/20 85.1 85.2 60.3 53.9
        >20/20 - < 20/40 14.9 14.9 34.7 38.5
        20/40 - < 20/100 0 0 3.0 5.5
        ≥20/100 0 0 2.0 2.1
Visual Acuity in the Better Eye (%) 0.0490
        ≤20/20 95.9 96.7 81.3 76.2
        >20/20 - < 20/40 4.1 3.3 17.9 21.9
        20/40 - < 20/100 0 0 0.5 1.7
        ≥20/100 0 0 0.3 0.2
Any Prior Ocular Surgeries in DCCT/EDIC (%) 0 0 8.6 14.9 0.0008
Renal Complications:
Any AER>300 ug/24hr or Sustained CKD GFR<60 mL/min/1.73 m (%) 0 0 8.4 16.6 <0.0001
Any Sustained AER>30 ug/24hr or CKD GFR<60 mL/min/1.73 m (%) 5.3 3.5 27.3 36.8 0.0004
Neuropathy Complications:
Abnormal Autonomic Response (%) 3.8 5.4 35.3 40.2 0.0872
Confirmed Clinical Neuropathy (%) 7.0 5.4 23.6 32.8 0.0004
Glycemic Control:
HbA1c (%) 9.0 (1.6) 8.9 (1.6) 8.0 (1.2) 7.9 (1.2) 0.3345
DCCT Mean HbA1c (%) ** - - 7.2 (0.8) 9.0 (1.2) <0.0001
EDIC Mean HbA1c (%) ** - - 8.0 (1.0) 8.0 (1.0) 0.5891

Data are means (standard deviation) or percent. There were not significant treatment group differences (p<0.05) at DCCT baseline with the exception of a marginally significant difference in age.

*

Mean arterial pressure was defined as 1/3 systolic blood pressure + 2/3 diastolic blood pressure.

Hypertension was defined by a systolic blood pressure of at least 140 mmHg, a diastolic blood pressure of at least 90 mmHg, documented hypertension, or the use of antihypertensive agents. Medication data was not collected during the DCCT.

Diabetes QOL is a self-administered multiple-choice 46-item assessment assessing different aspects of quality of life employed by DCCT.

§

Depression or psychiatric event is defined as at least one occurrence of nervousness or anxiety, affective disorder, suicide attempt in EDIC accompanied by hospitalization or out-patient treatment including tranquilizers.

Other ocular surgery includes glaucoma-related surgeries, corneal-related surgeries, YAG capsulotomy, and eye enucleation.

**

DCCT or EDIC mean hemoglobin HbA1c values are time-averaged throughout the DCCT or EDIC.

- Data not available or not applicable.